Clinical Trials Directory

Trials / Completed

CompletedNCT05927103

Differences Between Coffee and Non-coffee Drinkers in the Gut Microbiome and Microbiota-Gut-Brain Axis

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
University College Cork · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the potential of coffee to act as a prebiotic to alter gut microbiota and improve mood, memory and cognitive performance.

Detailed description

The aim of this study is to investigate the potential of coffee to act as a prebiotic to alter gut microbiota and improve mood, memory and cognitive performance in moderate coffee drinkers compared to non-coffee drinkers healthy adults. Reaction time, socioemotional processing, visual and episodic memory, learning, and an attentional task were administered to measure cognitive performance. Self-report questionnaires on mood, behavior and lifestyle were administered and response to an acute stressor was assessed. Biological samples of saliva, urine, blood, and stool were collected to investigate microbiome-gut-brain-axis signaling such as inflammation, short chain fatty acids and other metabolites production and physiological stress.

Conditions

Timeline

Start date
2021-09-21
Primary completion
2023-01-18
Completion
2023-01-18
First posted
2023-07-03
Last updated
2023-07-03

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT05927103. Inclusion in this directory is not an endorsement.